Organization
Zhejiang Chinese Medical University
3 clinical trials
2 abstracts
Abstract
A phase II study of liposomal irinotecan-based chemotherapy with or without PD-1 inhibitor in patients with unresectable locally advanced or metastatic biliary tract cancer.Org: Zhejiang Chinese Medical University,
Clinical trial
Multicenter Clinical and Basic Research on the Prevention and Treatment of 2019-nCoV by Integrated Traditional Chinese and Western MedicineStatus: Recruiting, Estimated PCD: 2024-06-01
Clinical trial
A Randomized Controlled Study on the Treatment of Postherpetic Neuralgia in the Head and Face With Superficial Needling Combined With ElectroacupunctureStatus: Recruiting, Estimated PCD: 2025-06-30
Clinical trial
Different Kinds of Acupuncture Treatment for Knee Osteoarthritis:a Multicentre Randomised Controlled TrialStatus: Completed, Estimated PCD: 2021-10-28
Abstract
Comparative efficacy and safety of anti-PD-1/L1 antibody plus anti-VEGF antibody and anti-PD-1/L1 antibody plus VEGFR-targeted tyrosine kinase inhibitor as first-line therapy for unresectable hepatocellular carcinoma (uHCC): A systematic review and network meta-analysis.Org: Chinese Academy of Sciences, Zhejiang Chinese Medical University,